A study analyzing effect of anti-cancer therapy on immunological response to COVID-19 vaccination
Latest Information Update: 25 Aug 2022
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics; Therapeutic Use
Most Recent Events
- 04 Jul 2022 Results presented at the 37th Congress of the European Association of Urology
- 01 Apr 2022 New trial record
- 19 Feb 2022 Results presented at the 2022 Genitourinary Cancers Symposium